← Eichor
Condition: Gefitinib Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Gefitinib

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosar
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07477457A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT01994057A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET
Phase N/A · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT06592989
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.